The invention
Development of safe and effective platform for administration of lutetium-177 DOTATOC peptide receptor radionuclide therapy for neuroendocrine tumours or other tumours highly expressing somatostatin receptors
The invention
- Name of invention
- Development of safe and effective platform for administration of lutetium-177 DOTATOC peptide receptor radionuclide therapy for neuroendocrine tumours or other tumours highly expressing somatostatin receptors
- Développement d'une plateforme sûre et efficace pour l'administration de radionucléides à base de récepteur peptidique lutétium-177 DOTATOC pour les tumeurs neuroendocrines ou d'autres tumeurs exprimant fortement les récepteurs de la somatostatine
Invention description
- Description
- We have invented a novel platform for effective and safe administration of lutetium-177 peptide receptor radionuclide therapy for neuroendocrine tumours, which has been clinically tested and proven safe in real patients.
INVENTORS
Chi Ang Nelson TO inventor 3727293071_3908
Kam-Man TAM inventor 3727293071_3906
Victor Ho-Fun LEE inventor 3727293071_3903
The University of Hong Kong inventor 3727293071_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.